Cargando…
Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer
Deleted in Liver Cancer-1 (DLC1), a member of the RhoGAP family of proteins, functions as a tumor suppressor in several cancers including breast cancer. However, its clinical relevance is unclear in breast cancer. In this study, expression of DLC1 was correlated with prognosis using publicly availab...
Autores principales: | Gökmen-Polar, Yesim, True, Jason D., Vieth, Edyta, Gu, Yuan, Gu, Xiaoping, Qi, Guihong D., Mosley, Amber L., Badve, Sunil S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168143/ https://www.ncbi.nlm.nih.gov/pubmed/30278072 http://dx.doi.org/10.1371/journal.pone.0204658 |
Ejemplares similares
-
Upregulation of HSF1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2016) -
Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022) -
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021) -
Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues
por: Chen, Yi, et al.
Publicado: (2019) -
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)